News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dendreon Corporation (DNDN)'s Prostate Cancer Vaccine Extends Survival In Eastern Virginia Medical School Study



4/29/2009 7:58:08 AM

Bookmark and Share

CHICAGO (AP) -- An experimental treatment added four months to the lives of men with advanced prostate cancer in a study that tested an entirely new approach to fighting the disease, doctors reported Tuesday.


Read at AP
Read at Los Angeles Times


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES